Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters – a pilot study
Anne Mehnert, Sivan Bershan, Jil Kollmus-Heege, Lea Gerischer, Meret Luise Herdick, Sarah Hoffmann, Sophie Lehnerer, Franziska Scheibe, Frauke Stascheit, Maike Stein, View ORCID ProfileAlastair M. Buchan, Andreas Meisel, Annette Aigner, View ORCID ProfilePhilipp Mergenthaler
doi: https://doi.org/10.1101/2023.09.19.23295421
Anne Mehnert
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
Sivan Bershan
2Charité – Universitätsmedizin Berlin, Center for Stroke Research Berlin, Berlin, Germany
Jil Kollmus-Heege
3Charité – Universitätsmedizin Berlin, Institute of Biometry and Clinical Epidemiology, Berlin, Germany
Lea Gerischer
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
4Charité – Universitätsmedizin Berlin, Neuroscience Clinical Research Center, Berlin, Germany
Meret Luise Herdick
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
4Charité – Universitätsmedizin Berlin, Neuroscience Clinical Research Center, Berlin, Germany
Sarah Hoffmann
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
4Charité – Universitätsmedizin Berlin, Neuroscience Clinical Research Center, Berlin, Germany
Sophie Lehnerer
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
4Charité – Universitätsmedizin Berlin, Neuroscience Clinical Research Center, Berlin, Germany
5Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany
Franziska Scheibe
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
Frauke Stascheit
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
4Charité – Universitätsmedizin Berlin, Neuroscience Clinical Research Center, Berlin, Germany
Maike Stein
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
4Charité – Universitätsmedizin Berlin, Neuroscience Clinical Research Center, Berlin, Germany
Alastair M. Buchan
2Charité – Universitätsmedizin Berlin, Center for Stroke Research Berlin, Berlin, Germany
6Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Andreas Meisel
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
2Charité – Universitätsmedizin Berlin, Center for Stroke Research Berlin, Berlin, Germany
4Charité – Universitätsmedizin Berlin, Neuroscience Clinical Research Center, Berlin, Germany
Annette Aigner
2Charité – Universitätsmedizin Berlin, Center for Stroke Research Berlin, Berlin, Germany
3Charité – Universitätsmedizin Berlin, Institute of Biometry and Clinical Epidemiology, Berlin, Germany
Philipp Mergenthaler
1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
2Charité – Universitätsmedizin Berlin, Center for Stroke Research Berlin, Berlin, Germany
6Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Article usage
Posted September 20, 2023.
Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters – a pilot study
Anne Mehnert, Sivan Bershan, Jil Kollmus-Heege, Lea Gerischer, Meret Luise Herdick, Sarah Hoffmann, Sophie Lehnerer, Franziska Scheibe, Frauke Stascheit, Maike Stein, Alastair M. Buchan, Andreas Meisel, Annette Aigner, Philipp Mergenthaler
medRxiv 2023.09.19.23295421; doi: https://doi.org/10.1101/2023.09.19.23295421
Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters – a pilot study
Anne Mehnert, Sivan Bershan, Jil Kollmus-Heege, Lea Gerischer, Meret Luise Herdick, Sarah Hoffmann, Sophie Lehnerer, Franziska Scheibe, Frauke Stascheit, Maike Stein, Alastair M. Buchan, Andreas Meisel, Annette Aigner, Philipp Mergenthaler
medRxiv 2023.09.19.23295421; doi: https://doi.org/10.1101/2023.09.19.23295421
Subject Area
Subject Areas
- Addiction Medicine (326)
- Allergy and Immunology (642)
- Anesthesia (170)
- Cardiovascular Medicine (2452)
- Dermatology (208)
- Emergency Medicine (384)
- Epidemiology (11895)
- Forensic Medicine (10)
- Gastroenterology (707)
- Genetic and Genomic Medicine (3827)
- Geriatric Medicine (356)
- Health Economics (646)
- Health Informatics (2469)
- Health Policy (954)
- Hematology (348)
- HIV/AIDS (806)
- Medical Education (379)
- Medical Ethics (105)
- Nephrology (409)
- Neurology (3595)
- Nursing (202)
- Nutrition (536)
- Oncology (1865)
- Ophthalmology (544)
- Orthopedics (227)
- Otolaryngology (293)
- Pain Medicine (235)
- Palliative Medicine (68)
- Pathology (457)
- Pediatrics (1057)
- Primary Care Research (432)
- Public and Global Health (6257)
- Radiology and Imaging (1317)
- Respiratory Medicine (842)
- Rheumatology (387)
- Sports Medicine (332)
- Surgery (417)
- Toxicology (51)
- Transplantation (177)
- Urology (149)